(Applicant's Description) The Vanderbilt Cancer Center is a comprehensive, multidisciplinary clinical and laboratory research center. The Vanderbilt Cancer Center integrates the cancer-related expertise and resources of the School of Medicine, Vanderbilt University Hospital, and the Vanderbilt Clinic within the Vanderbilt Univer- sity Medical Center; the fully integrated Veterans Administration (VA) Medical Center and the Departments of Chemistry and Molecular Biology in the School of Arts and Sciences. All facilities are located in close proximity on the same campus, a situation which promotes interactions, sharing of resources and collaborations. Established in 1993, the Vanderbilt Cancer Center functions as an organizational unit with a supradepartmental status. The Vanderbilt Cancer Center's specific authorities and responsibilities are: (1) To coordinate and integrate the cancer and cancer-related activities of Vanderbilt University. (2) To conduct, support and enhance cancer research and to integrate cancer-related research throughout the University. (3) To integrate, develop, and conduct cancer education programs. (4) To coordinate and integrate the care of cancer patients at Vanderbilt University Medical Center and the Veterans Administration Medical Center. The research objectives are accomplished through eight research programs and nine shared resources: Programs: (1) Signal Transduction, (2) Regulation of Cell Proliferation, (3) Gastrointestinal Cancer, (4) Cancer Etiology, (5) Cancer Genetics, (6) Breast Cancer, (7) Cancer Pharmacology, (8) Clinical Investigations; Shared Resources: (1) Biostatistics/Data Management, (2) Bioanalytical, (3) Cell Imaging, (4) DNA Sequencing, (5) Genetics, (6) Peptide Sequencing and Amino Acid Analysis, (7) Transgenic Mouse/ES Cell, (8) Human Tissue Acquisition and Pathology, and (9) Viral Vector. Integration of all cancer-related activities under the authority of the Vanderbilt Cancer Center provides an effective administrative structure to promote novel interactive approaches to cancer research, and partial support for this research infrastructure is requested in this application for a Cancer Center Support Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA068485-03S1
Application #
2859161
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Bhorjee, Jaswant
Project Start
1998-09-01
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Maacha, Selma; Hong, Jun; von Lersner, Ariana et al. (2018) AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 20:1008-1022
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Wang, Jing; Zhao, Yue; Zhou, Xiaofan et al. (2018) Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19:633
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719

Showing the most recent 10 out of 2462 publications